Randomized phase II trial of S-1 versus S-1 plus irinotecan (IRIS) in patients with gemcitabine-refractory pancreatic cancer.
暂无分享，去创建一个
J. Furuse | Masao Tanaka | T. Kudo | Tetsuhide Ito | Taketo Yamaguchi | M. Kitano | N. Mizuno | K. Yamao | Y. Sakata | K. Takeda | T. Ioka | C. Hamada | Y. Komatsu | A. Tsuji | S. Ohkawa | H. Iguchi | A. Ishiguro | M. Munakata | M. Kida